STERIS vs United Therapeutics
STERIS (STE), health care, and United Therapeutics (UTHR), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
STERIS and United Therapeutics are valued at about the same: $25B and $24.9B. STERIS trades at 30.5 times earnings and United Therapeutics at 22.0; operating margins in their latest fiscal years were 18.6% and 46.9%. Over the past year STERIS's share price has moved +1.91% and United Therapeutics's +23.4%.
Key facts
- STERIS market value
- $25B
- United Therapeutics market value
- $24.9B
- STERIS P/E
- 30.5
- United Therapeutics P/E
- 22.0
- STERIS revenue
- $5.9BFY to 2026-03-31
- United Therapeutics revenue
- $3.2BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | STERIS | United Therapeutics |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2026-03-31 | 2025-12-31 |
| Size | ||
| Market cap | $25Bhigher | $24.9Blower |
| Revenue | $5.9Bhigher | $3.2Blower |
| Earnings | $782.3Mlower | $1.3Bhigher |
| Employees | 17,937higher | 1,400lower |
| Total assets | $10.7Bhigher | $7.9Blower |
| Valuation | ||
| P/E | 30.5higher | 22.0lower |
| P/S | 4.2lower | 7.8higher |
| P/B | — | 3.9 |
| Dividend yield | — | 0.00% |
| Profitability | ||
| Operating margin | 18.6%lower | 46.9%higher |
| Balance sheet | ||
| Net assets | $7.2Bhigher | $7.1Blower |
| Total liabilities | $3.5Bhigher | $783.8Mlower |
| Total debt | $1.9B | — |
| Cash on hand | $439.6Mlower | $1.6Bhigher |
| Price change | ||
| Today | -1.46%lower | -0.64%higher |
| 1 year | +1.91%lower | +23.4%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
STERIS only (1)
- Joel Greenblatt0.1%
United Therapeutics only (4)
Percentages are each holding's share of that investor's reported portfolio. Who owns STE · Who owns UTHR
More on STERIS
Further comparisons
STERIS against its closest peers
United Therapeutics against its closest peers
Learn
Questions and answers
Which is bigger, STERIS or United Therapeutics?
By market value, STERIS is the larger: $25B against $24.9B for United Therapeutics. By revenue in its latest fiscal year, STERIS is the larger: $5.9B against $3.2B for United Therapeutics.
Which has the higher P/E ratio?
STERIS: 30.5, against 22.0 for United Therapeutics. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
United Therapeutics: 46.9%, against 18.6% for STERIS. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which superinvestors own both STERIS and United Therapeutics?
None of the tracked superinvestors holds both in their latest 13F filing. 1 holds STERIS and 4 hold United Therapeutics.
Cite this page
Funkfolio, “STERIS vs United Therapeutics”, data as of 17 November 2026. https://funkfolio.com/compare/ste-vs-uthr
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.